Indivior, GB00BYZ0C031

Indivior stock gains on $8.13 special dividend

Published on 09/17/2026 at 23:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Indivior stock closed at USD 34.35 on September 16, 2026, and the board declared a $8.13 special dividend. Barclays kept Overweight with a USD 43 target on August 5, 2026.

Moderne Pharma-Produktionsanlage mit Glasfassade und Industrieanlagen im Tageslicht
Indivior PLC mit ISIN GB00BYZ0C031 betreibt moderne Pharma-Produktionsanlage für innovative Suchtmedizin-Präparate weltweit an Patienten, Illustration mit AI erstellt.

Indivior stock (GB00BYZ0C031) closed at USD 34.35 on the Nasdaq on September 16, 2026, up 0.38 percent, with intraday trading between USD 33.84 and USD 34.54 and a market value of USD 4.054 billion.

$8.13 dividend

On September 17, 2026, Indivior said its board declared a special cash dividend of USD 8.13 per share, payable only if the pending merger with Supernus closes. The company said the record date is October 30, 2026, and the merger is expected on or about November 2, 2026, with dividend payment anticipated on or about November 6, 2026.

That dividend is larger than one quarter of the current share price, which makes the merger timetable the key variable for investors. The same release said the cash payment is contingent on stockholder approvals and closing conditions.

Barclays cuts target

Yahoo Finance shows the latest analyst update for Indivior on August 5, 2026: Barclays kept Overweight and lowered its price target to USD 43 from USD 46. The portal also shows an average target of USD 49 and a high target of USD 53.

Yahoo Finance also shows second-quarter 2026 revenue of USD 343 million, earnings of USD 122 million and a profit margin of 35.57 percent, with adjusted EPS of USD 1.15 versus an estimate of USD 0.92. That is a beat of USD 0.23 per share in Q2 FY26.

Price and range

As of September 16, 2026, Indivior traded at USD 34.35, within a 52-week range of USD 22.22 to USD 42.81, and the Nasdaq quote page showed 1,865,881 shares in volume and a current-year return of 4.26 percent.

Indivior stock key data

  • Company: Indivior Pharmaceuticals, Inc.
  • ISIN: GB00BYZ0C031
  • Ticker: INDV
  • Trading venue: Nasdaq
  • Price (as of September 16, 2026): USD 34.35
  • Market capitalization: USD 4.054 billion (as of September 16, 2026)
  • Sector / Industry: Healthcare / Drug Manufacturers - Specialty & Generic
  • Index membership: Nasdaq Composite
  • Next earnings date: November 5, 2026

More news and analyses on Indivior stock

Disclaimer...

en | GB00BYZ0C031 | INDIVIOR | boerse | 70120985 | bgmi